Papers/PMID:36863217
High serum riboflavin is associated with the risk of sporadic colorectal cancer.
Cancer epidemiology2023The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
riboflavin — increases colorectal cancer incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“After fully adjusting for the confounding factors, an increased risk of colorectal cancer was suggested for individuals with higher levels of serum riboflavin (OR = 1.08 (1.01, 1.15), p = 0.03) in a dose-response relationship.”
Quoted verbatim from High serum riboflavin is associated with the risk of sporadic colorectal cancer.. - Study
- case-control
- Population
- Adults at one Shanghai hospital: sporadic colorectal cancer patients without family history and healthy controls; exposure is endogenous serum riboflavin level, not an administered dose
Effect 1.08 odds ratio, 95% CI 1.01 to 1.15
High serum riboflavin is associated with the risk of sporadic colorectal cancer.2023PMID:36863217Permalink